Image

Functional Inspiratory Muscle Training in Obese Individuals

Functional Inspiratory Muscle Training in Obese Individuals

Recruiting
25-60 years
All
Phase N/A

Powered by AI

Overview

In obese individuals, increased adipose tissue and systemic inflammation play a key role in the development of cardiometabolic diseases, pulmonary system dysfunction, and many respiratory diseases. Existing research has demonstrated beneficial clinical outcomes of inspiratory muscle training or combined aerobic and resistance exercise training in obese individuals. However, this focused on the isolated effects of exercise on obesity. In the current literature, no study is evaluating the effectiveness of functional inspiratory muscle training in obese individuals.

This study aims to investigate the effects of functional inspiratory muscle training on body composition, cardiometabolic markers, functional capacity, respiratory function, respiratory muscle strength, and respiratory muscle performance in obese individuals.

Description

Obesity is characterized by increased adipose tissue and systemic inflammation that play a key role in the development of non-communicable chronic diseases. It is well known that individuals with obesity have decreased exercise capacity and muscle weakness in both peripheral and respiratory muscles.

Exercise training is recommended in addition to healthy dietary habits in managing obesity. Current literature demonstrated beneficial clinical outcomes of isolated inspiratory muscle training or combined aerobic and resistance exercise training in obese individuals.

Functional inspiratory muscle training is a method that combines both aerobic exercise and inspiratory muscle training. In the current literature, no study is evaluating the effectiveness of functional inspiratory muscle training in obese individuals. The aim of this study is to investigate the effect of functional inspiratory muscle training on body composition, cardiometabolic markers, functional capacity, respiratory function, respiratory muscle strength and respiratory muscle performance in obese individuals.

Eligibility

Inclusion Criteria:

  • Those between the ages of 25-60
  • According to the World Health Organization (WHO) classification, those with a body mass index between 30-40 kg/m2
  • Volunteering to participate in the research

Exclusion Criteria:

  • According to the World Health Organization (WHO) classification, body mass index is over 40 kg/m2
  • Functional class III or IV according to the New York Heart Association (NYHA) classification
  • Those with a Charlson comorbidity score of 3 and above
  • Uncontrolled hypertension, diabetes and unstable angina pectoris
  • Cooperative disorders, orthopedic and neurological problems that may interfere with evaluation and treatment
  • Individuals with a history of lower extremity-related injury or surgery in the last six months
  • Being diagnosed with diabetes and having complications such as nephropathy, retinopathy and neuropathy
  • Those with accompanying chronic respiratory disease
  • Those with acute infection
  • Individuals with middle ear-related pathologies (such as tympanic membrane rupture, otitis)
  • Those with a STOP-Bang score of 3 and above
  • Individuals with a history of spontaneous or trauma-related pneumothorax
  • Smokers
  • Pregnancy

Study details
    Obesity

NCT06280183

Biruni University

16 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.